Travoprost: all 80 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle GlaucomaRecruitingNCT07228221Phase 4
• Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneRecruitingNCT06848946Phase 4
• Performance of the Travoprost Intraocular ImplantCompletedNCT06582732Phase 2Results posted
• Study of Exchange of Travoprost Intraocular ImplantCompletedNCT04615403Phase 2Results posted
• Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®CompletedNCT03965052Phase 1Results posted
• Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHTCompletedNCT02914509Phase 3Results posted
• Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT02796560Phase 4Results posted
• Stop Retinal Ganglion Cell Dysfunction StudyTerminatedNCT02390284Phase 3Results posted
• Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02097719Phase 4Results posted
• Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension GlaucomaCompletedNCT01995136Phase 4Results posted
• An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01881126Phase 4Results posted
• Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle GlaucomaCompletedNCT01711177Not applicableResults posted
• An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®CompletedNCT01664039Phase 4Results posted
• Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma PatientsCompletedNCT01652664Phase 3Results posted
• Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) ReductionCompletedNCT01547598Phase 4Results posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01510145Phase 4Results posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01493427Phase 4Results posted
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)CompletedNCT01464424Phase 4Results posted
• Travoprost 3-Month Safety and Efficacy StudyCompletedNCT01453855Phase 3Results posted
• Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololCompletedNCT01336569Phase 4Results posted
• Efficacy of Changing to DUOTRAV® From Prior TherapyCompletedNCT01327599Phase 4Results posted
• Effects of Anti-Glaucoma Medications on the Ocular SurfaceTerminatedNCT01315574Phase 4Results posted
• Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01253902Phase 4Results posted
• Travoprost Five Day Posology StudyCompletedNCT01114893Phase 2Results posted
• Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00966940Phase 4Results posted
• Efficacy Study of Travoprost APS Versus TRAVATANCompletedNCT00848536Phase 3Results posted
• Examination of Ocular Surface Effects With Administration of Travatan Z and XALATANCompletedNCT00798759Phase 4Results posted
• How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?CompletedNCT00798694Phase 4Results posted
• Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular HypertensionCompletedNCT00763061Phase 4Results posted
• Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)CompletedNCT00762645Phase 4Results posted
• Phase III Clinical Trial of TRAVATAN Z in Ocular Surface HealthCompletedNCT00761319Phase 3Results posted
• Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)TerminatedNCT00758342Phase 4Results posted
• Effects of Travatan Z and Xalatan on Ocular Surface HealthCompletedNCT00708422Phase 4Results posted
• The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the EyeCompletedNCT00705757Phase 4Results posted
• Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00690794Phase 3Results posted
• A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00527592Phase 4Results posted
• Adherence Assessment With Travalert Dosing AidCompletedNCT00508469Phase 4Results posted
• A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular HypertensionCompletedNCT00471380Phase 4Results posted
• Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular HypertensionTerminatedNCT00471068Phase 4Results posted
• A Long-term Safety Study of Once-daily TravatanCompletedNCT00051168Phase 3Results posted
• Travoprost Intraocular Implant in Conjunction With Cataract SurgeryActive, not recruitingNCT06061718Phase 3
• Interval Intraocular Pressure in Intravitreal Injection StudyCompletedNCT04868175Not applicable
• Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of VitiligoStatus unknownNCT04577027Phase 4
• Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle GlaucomaCompletedNCT03966560Phase 4
• Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive AgentsCompletedNCT02873806Phase 4
• Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular HypertensionCompletedNCT02312544Phase 2
• Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal EyesCompletedNCT02136589Phase 4
• Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in RussiaWithdrawnNCT01696383Phase 4
• 24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionCompletedNCT01655758Phase 4
• Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment EffectCompletedNCT01491867Not applicable
• AR-12286 Fixed Dose Combination to Lower Elevated Intraocular PressureCompletedNCT01474135Phase 2
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or TravoprostCompletedNCT01444040Phase 4
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or TravoprostCompletedNCT01443988Phase 4
• Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant GlaucomaStatus unknownNCT01361841Not applicable
• Divided Dose of TRAVATAN®CompletedNCT01298687Phase 2
• Safety and Efficacy of Changing to DuoTrav From Prior TherapyCompletedNCT01230736Phase 4
• Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00872651Phase 3
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompletedNCT00847483Phase 4
• Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®CompletedNCT00799682Phase 4
• 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPTTerminatedNCT00767481Phase 3
• Safety and Efficacy of Travoprost/Timolol BAC-freeCompletedNCT00760539Phase 3
• Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00759239Phase 4
• A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00672997Phase 3
• Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00670033Phase 2
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00527501Phase 2
• Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTravCompletedNCT00519753Phase 4
• Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy VolunteersCompletedNCT00468988Phase 4
• A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular HypertensionCompletedNCT00465803Phase 3
• Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin TherapyCompletedNCT00444665Phase 4
• Effects of Travoprost on Neovascular GlaucomaWithdrawnNCT00441181Not applicable
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00333125Phase 3
• A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00311389Phase 3
• Influence of Prostaglandins on Ocular Blood Flow in Glaucoma PatientsCompletedNCT00308945Phase 4
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293800Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293787Phase 3
• Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00288951Phase 3
• Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to TravatanCompletedNCT00121147Not applicable
• Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT00061503Phase 4
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure GlaucomaCompletedNCT00051181Phase 3
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT00051142Phase 3

← Travoprost overview